Benjamin J. Thompson

1.8k citations

22 papers · 1.3k indexed · h-index 11

Molecular Biology top 10%
Hematology top 5%
Oncology top 10%
Public Health, Environmental and Occupational Health top 10%
Immunology top 10%

Co-authors: Iannis Aifantis Silvia Buonamici Teresa Palomero Adolfo A. Ferrando Tomas Vilimas Giuseppe Basso Maria Luisa Sulis Jiří Zavadil
Topics: Proteoglycans and glycosaminoglycans research (4 papers)Fibroblast Growth Factor Research (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)
Cited by: Hematology Molecular Biology Cancer Research
Journals: Nature Medicine The Journal of Experimental Medicine Journal of Clinical Oncology
Partner nations: United States United Kingdom France

In The Last Decade

Benjamin J. Thompson

21 papers receiving 1.3k citations

Peers

Countries citing papers authored by Benjamin J. Thompson

Since Specialization

Citations

This map shows the geographic impact of Benjamin J. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin J. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin J. Thompson more than expected).

Fields of papers citing papers by Benjamin J. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin J. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin J. Thompson. The network helps show where Benjamin J. Thompson may publish in the future.

Co-authorship network of co-authors of Benjamin J. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin J. Thompson. A scholar is included among the top collaborators of Benjamin J. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin J. Thompson. Benjamin J. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	764 A phase 1, first-in-human (FIH), open-label, dose-finding and expansion study of XmAb808, a B7H3 x CD28 bispecific antibody, in combination with pembrolizumab in patients with advanced solid tumors 2023 ·SHILAP Revista de lepidopterología ·Manojkumar Bupathi,(unknown),Siwen Hu‐Lieskovan,Sarina A. Piha‐Paul,Bartosz Chmielowski,(unknown),Yana G. Najjar,Mark N. Stein,(unknown),Jitendra Kanodia,Raphael Clynes,(unknown),Benjamin J. Thompson	3
2	A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3). 2022 ·Journal of Clinical Oncology ·Mehmet Akce,Siwen Hu‐Lieskovan,Matthew J. Reilley,James Strauss,Jennifer M. Specht,Mark N. Stein,Judy S. Wang,Jennifer H. Choe,Rom S. Leidner,Diwakar Davar,Gerald S. Falchook,Shubham Pant,Ezra E.W. Cohen,Breelyn A. Wilky,Benjamin J. Thompson,Raphael Clynes,Lingling Li,(unknown),David Liebowitz	8
3	The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44 2019 ·Oncotarget ·Chun‐Mei Zhao,Benjamin J. Thompson,Kelly Chen,Feng Gao,Barbara Blouw,Mathieu Marella,(unknown),(unknown),(unknown),(unknown),Lei Huang,Zhongdong Huang,H. Michael Shepard,Sanna Rosengren,Christopher D. Thanos,Daniel C. Maneval	7
4	Abstract 1743: Rationale for evaluating PEGylated recombinant human hyaluronidase PH20 (pegvorhyaluronidase alfa; PEGPH20) in patients with hyaluronan (HA)-accumulating colorectal cancer 2018 ·Cancer Research ·(unknown),Benjamin J. Thompson,Darin Taverna,Barbara Blouw,Ji Sook Lee,Curtis B. Thompson,Daniel C. Maneval	1
5	PO-262 Remodelling of the tumour microenvironment by pegvorhyalurondiase alfa (PEGPH20): a novel, first-in-class biologic that enzymatically degrades tumour hyaluronan (HA) to improve anti-tumour efficacy 2018 ·ESMO Open ·Benjamin J. Thompson,(unknown),(unknown),Darin Taverna,(unknown),Barbara Blouw,(unknown),Curtis B. Thompson,Daniel C. Maneval	0
6	Abstract B38: Increasing tumor-infiltrating CD8+ T cell response and checkpoint inhibitor efficacy by enzymatic reduction of tumor hyaluronan in a murine syngeneic pancreatic cancer model 2018 ·Cancer Immunology Research ·Benjamin J. Thompson,(unknown),Barbara Blouw,(unknown),Yujun Huang,Sanna Rosengren,Curtis B. Thompson,Ji‐Sook Lee	2
7	The mitochondrial respiratory chain is essential for haematopoietic stem cell function 2017 ·Nature Cell Biology ·Elena Ansó,Samuel E. Weinberg,Lauren Diebold,Benjamin J. Thompson,Sébastien Malinge,Paul T. Schumacker,Xin Liu,Yuannyu Zhang,Zhen Shao,Mya Steadman,(unknown),Jian Xu,John D. Crispino,Navdeep S. Chandel	221
8	Abstract 4886: PEGylated recombinant hyaluronidase PH20 (PEGPH20) enhances checkpoint inhibitor efficacy in syngeneic mouse models of cancer 2016 ·Cancer Research ·Sanna Rosengren,(unknown),(unknown),(unknown),Benjamin J. Thompson,Barbara Blouw,Xiaoming Li,Qiping Zhao,Michael Shepard,(unknown),Christopher D. Thanos,Curtis B. Thompson	8
9	DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3 2015 ·The Journal of Experimental Medicine ·Benjamin J. Thompson,Rahul S. Bhansali,Lauren Diebold,Daniel E. Cook,Lindsay R. Stolzenburg,(unknown),Thierry Besson,Bertrand Leblond,Laurent Désiré,Sébastien Malinge,John D. Crispino	50
10	The Chromosome 21 Kinase DYRK1A Controls Cell Cycle Exit and Survival During Lymphoid Development and Is a Novel Therapeutic Target In Acute Lymphoblastic Leukemia 2013 ·Blood ·Benjamin J. Thompson,Lauren Diebold,Sébastien Malinge,Bertrand Leblond,(unknown),Laurent Désiré,(unknown),Thierry Besson,Nobuko Hijiya,John D. Crispino	1
11	Dissecting the complete lipoprotein biogenesis pathway in Streptomyces scabies 2011 ·Molecular Microbiology ·David A. Widdick,Matthew G. Hicks,Benjamin J. Thompson,Andreas Tschumi,Govind Chandra,Iain C. Sutcliffe,(unknown),Peter Sander,Tracy Palmer,Matthew I. Hutchings	38
12	Investigating lipoprotein biogenesis and function in the model Gram‐positive bacterium Streptomyces coelicolor 2010 ·Molecular Microbiology ·Benjamin J. Thompson,David A. Widdick,Matthew G. Hicks,Govind Chandra,Iain C. Sutcliffe,Tracy Palmer,Matthew I. Hutchings	54
13	Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase–substrate complex 2010 ·Nature Immunology ·Linsey B. Reavie,Giusy Della Gatta,(unknown),Beatriz Aranda-Orgillés,Shannon M. Buckley,Benjamin J. Thompson,Eugine Lee,Jie Gao,Andrea Bredemeyer,Beth A. Helmink,Jiří Zavadil,Barry P. Sleckman,Teresa Palomero,Adolfo A. Ferrando,Iannis Aifantis	97
14	Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7 2008 ·The Journal of Experimental Medicine ·Benjamin J. Thompson,Vladimir Janković,Jie Gao,Silvia Buonamici,(unknown),(unknown),Jiří Zavadil,Stephen D. Nimer,Iannis Aifantis	145
15	Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7 2008 ·The Journal of Cell Biology ·Benjamin J. Thompson,Vladimir Janković,Jie Gao,Silvia Buonamici,(unknown),(unknown),Jiří Zavadil,Stephen D. Nimer,Iannis Aifantis	2
16	The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia 2007 ·The Journal of Experimental Medicine ·Benjamin J. Thompson,Silvia Buonamici,Maria Luisa Sulis,Teresa Palomero,Tomas Vilimas,Giuseppe Basso,Adolfo A. Ferrando,Iannis Aifantis	363
17	Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia 2006 ·Nature Medicine ·Tomas Vilimas,Joaquina Mascarenhas,Teresa Palomero,Malay Mandal,Silvia Buonamici,Fanyong Meng,Benjamin J. Thompson,Christina Spaulding,(unknown),Maria‐Luisa Alegre,Barbara L. Kee,Adolfo A. Ferrando,Lucio Miele,Iannis Aifantis	261
18	The Temperature Dependence of the Inositol Monophosphatase K_m Correlates with Accumulation of Di-myo-inositol 1,1‘-Phosphate in Archaeoglobus fulgidus 2006 ·Biochemistry ·(unknown),Adam J. Morgan,Kimberly A. Stieglitz,Boguslaw Stec,Benjamin J. Thompson,Scott J. Miller,Mary F. Roberts	18
19	Expression proteomics identifies biochemical adaptations and defense responses in transgenic plants with perturbed polyamine metabolism 2004 ·FEBS Letters ·Marina Franceschetti,Barry Perry,Benjamin J. Thompson,Colin Hanfrey,Anthony J. Michael	9
20	Transcription Factor FnrP from Paracoccus denitrificans Contains an Iron-Sulfur Cluster and Is Activated by Anoxia: Identification of Essential Cysteine Residues 2002 ·Journal of Bacteriology ·Matthew I. Hutchings,Jason C. Crack,Neil Shearer,Benjamin J. Thompson,Andrew J. Thomson,Stephen Spiro	22

About Benjamin J. Thompson

Benjamin J. Thompson is a scholar working on Immunology, Hematology and Cell Biology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (4 papers), Fibroblast Growth Factor Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Hematology (301 citations), Molecular Biology (901 citations) and Cancer Research (191 citations). Benjamin J. Thompson has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Iannis Aifantis, Silvia Buonamici, Teresa Palomero, Adolfo A. Ferrando, Tomas Vilimas, Giuseppe Basso, Maria Luisa Sulis, Jiří Zavadil, John D. Crispino and Lauren Diebold. Their work appears in journals such as Nature Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact